Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. A
A logo

A News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

A News

Vertex Pharmaceuticals Stock Performance Strong

3d agoCNBC

Synthego Welcomes Supreme Court Ruling Finalizing Invalidation of Agilent CRISPR Patents

Apr 01 2026Yahoo Finance

The Overlooked Sector of Healthcare That Has Captivated Wall Street

Mar 29 2026Marketbeat

Agilent Receives FDA Approval for New Diagnostic Tool

Mar 26 2026NASDAQ.COM

Agilent Receives FDA Approval for New Diagnostic Tool

Mar 26 2026Newsfilter

Crawford & Company Appoints New CEO

Mar 23 2026seekingalpha

Agilent Launches Advanced Therapeutics CDMO Solution

Mar 11 2026Newsfilter

Agilent Acquires Biocare Medical for $950 Million

Mar 09 2026Benzinga

A Events

04/01 08:11
Agilent Launches BioTek Cytation 9 Multimode Cell Imaging Reader
Agilent Technologies announced the launch of the BioTek Cytation 9 cell imaging multimode reader, the newest addition to the Cytation portfolio combining multimode microplate reading and high-content cell imaging in a single platform. Building on a decade of Cytation innovation and shaped by continuous customer feedback, the BioTek Cytation 9 helps laboratories move from samples to insights faster, supporting workflows from basic research through high-content screening. Designed for researchers running both cell-based and biochemical assays, Cytation 9 brings expanded imaging capabilities along with advanced hybrid microplate detection technologies. Key features include inverted fluorescence microscopy, upright imaging, and a multimode microplate reader module in a single instrument, helping laboratories streamline workflows while maintaining flexibility across diverse applications.

A Monitor News

Agilent's Acquisition of Biocare Aims to Boost Pathology Market Position

Mar 12 2026

Agilent Technologies Sets FY26 Revenue Target Amid Q1 Disappointment

Feb 26 2026

Agilent's PD-L1 Diagnostic Tool Approved for KEYTRUDA Treatment

Feb 12 2026

Agilent Technologies to Release Q1 FY2026 Financial Results

Feb 09 2026

Analysts Upgrade Agilent with Buy Rating and $180 Target

Jan 23 2026

Analysts Upgrade Agilent with Buy Rating and $180 Target

Jan 20 2026

Agilent Technologies reaches 20-day high amid market strength

Jan 06 2026

Agilent Declares Quarterly Dividend

Nov 25 2025

A Earnings Analysis

Agilent Technologies Q4 Earnings Exceed Expectations- Intellectia AI™
4 months ago
Agilent Q1 2025 Earnings: Growth and Strategic Focus- Intellectia AI™
1 years ago
Agilent Technologies Inc Reports Q4 FY2024 Financial Results
1 years ago

People Also Watch